ADC Therapeutics S.A. (ADCT) Social Stream



ADC Therapeutics S.A. (ADCT): $4.96

0.52 (+11.71%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

C

Add ADCT to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#135 of 363

in industry

ADC THERAPEUTICS SA (ADCT) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering ADCT.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-01-26 7 $55 $34 $43.714 $1.66 2533.37%
2022-02-08 7 $55 $29 $41.142 $1.66 2378.43%
2022-04-12 7 $54 $26 $37.285 $1.66 2146.08%
2022-04-19 7 $54 $26 $37.142 $1.66 2137.47%
2022-05-10 6 $54 $30 $38 $1.66 2189.16%
2022-05-23 6 $54 $17 $35.833 $1.66 2058.61%
2022-06-15 6 $54 $17 $33 $1.66 1887.95%
2022-07-14 6 $44 $17 $31.333 $1.66 1787.53%
2022-08-09 6 $44 $16 $31.166 $1.66 1777.47%
2022-08-13 6 $44 $15 $29 $1.66 1646.99%
2022-08-22 6 $44 $15 $25 $1.66 1406.02%
2022-09-17 6 $44 $11 $24 $1.66 1345.78%
2022-09-19 7 $44 $11 $24.166 $1.66 1355.78%
2022-09-21 7 $44 $5 $21.428 $1.66 1190.84%
2022-10-21 7 $44 $5 $21.285 $1.66 1182.23%
2022-11-08 7 $44 $5 $21.285 $1.66 1182.23%
2022-11-09 7 $25 $5 $14.833 $1.66 793.55%
2022-11-14 7 $25 $5 $14.166 $1.66 753.37%
2022-12-19 8 $25 $5 $13.857 $1.66 734.76%
2023-01-25 8 $25 $5 $13.714 $1.66 726.14%
2023-03-03 8 $25 $5 $13.428 $1.66 708.92%
2023-03-09 7 $20 $5 $12.285 $1.66 640.06%
2023-04-21 8 $20 $5 $12.285 $1.66 640.06%
2023-04-24 8 $20 $2 $11.571 $1.66 597.05%
2023-05-09 8 $20 $2 $12.666 $1.66 663.01%
2023-05-16 8 $20 $2 $9.857 $1.66 493.8%
2023-06-06 8 $20 $2 $10.666 $1.66 542.53%
2023-07-11 8 $17 $2 $9.333 $1.66 462.23%
2023-08-09 8 $17 $2 $8.333 $1.66 401.99%
2023-09-11 8 $17 $2 $8.166 $1.66 391.93%
2023-09-19 7 $17 $2 $9 $1.66 442.17%
2023-10-17 7 $17 $1 $8.8 $1.66 430.12%
2023-11-02 7 $17 $0.7 $8.74 $1.66 426.51%
2023-11-13 7 $17 $0.7 $8.74 $1.66 426.51%
2023-11-20 7 $17 $0.7 $6.94 $1.66 318.07%

The Trend in the Analyst Price Target


ADCT's average price target has moved down $2.39 over the prior 153 days.

Over the past 46 weeks, ADCT's average upside potential has been 544.96%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-05-16 8 20 2 10.666 2.440 337.13%
2023-08-09 8 17 2 8.166 1.500 444.4%
2023-08-09 8 17 2 8.333 1.500 455.53%
2023-09-14 8 17 2 7.833 0.873 797.25%
2023-10-17 7 17 1 8.800 0.766 1048.83%

ADCT Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.14 3 1 2 0 0 7

The Trend in the Broker Recommendations


ADCT's average broker recommendation rating worsened by 0.71 over the prior 13 months.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ADCT as an investment opportunity.

  • ADC THERAPEUTICS SA's upside potential (average analyst target price relative to current price) is higher than 3851.21% of all US stocks.
  • ADC THERAPEUTICS SA's variance in analysts' estimates is lower than -3558.23% of all US stocks.
  • In the context of stocks in the mid market cap category, ADC THERAPEUTICS SA's average analyst price target is greater than 1064.18% of them.
  • To contextualize these metrics, consider that out of stocks in the mid market cap category, ADC THERAPEUTICS SA's number of analysts covering the stock is higher than 1739.98% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to ADC THERAPEUTICS SA are ROIV, LYEL, and AMLX.

Make investment decisions regarding ADCT using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!